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ABSTRACT
Interferon-induced proteins with tetratricopeptide re-
peats (IFITs) are highly expressed during the cell-
intrinsic immune response to viral infection. IFIT1 in-
hibits translation by binding directly to the 5′ end of
foreign RNAs, particularly those with non-self cap
structures, precluding the recruitment of the cap-
binding eukaryotic translation initiation factor 4F
and ribosome recruitment. The presence of IFIT1 im-
poses a requirement on viruses that replicate in the
cytoplasm to maintain mechanisms to avoid its re-
strictive effects. Interaction of different IFIT family
members is well described, but little is known of the
molecular basis of IFIT association or its impact on
function. Here, we reconstituted different complexes
of IFIT1, IFIT2 and IFIT3 in vitro, which enabled us
to reveal critical aspects of IFIT complex assembly.
IFIT1 and IFIT3 interact via a YxxxL motif present
in the C-terminus of each protein. IFIT2 and IFIT3
homodimers dissociate to form a more stable het-
erodimer that also associates with IFIT1. We show
for the first time that IFIT3 stabilizes IFIT1 protein ex-
pression, promotes IFIT1 binding to a cap0 Zika virus
reporter mRNA and enhances IFIT1 translation inhi-
bition. This work reveals molecular aspects of IFIT
interaction and provides an important missing link
between IFIT assembly and function.
INTRODUCTION
The host innate immune response provides a first line
defence against invading pathogens. Following infection,
pathogen recognition receptors (PRRs) sense non-self,
pathogen-associated molecular patterns (PAMPs) trigger-
ing signaling pathways that activate an immune response
(reviewed in 1). Detection of viral signatures by PRRs, such
as RIG I-like receptor sensing of double stranded RNA, in-
duces production of Type I and Type III interferon (IFN).
Through binding of cell surface IFN receptors and sub-
sequent activation of the JAK-STAT pathway, IFN acti-
vates the transcription of hundreds of IFN-stimulated genes
(ISGs) (2), many with known antiviral properties, priming
neighbouring cells to restrict viral spread.
The interferon induced protein with tetratricopeptide re-
peats (IFIT) protein family, present in all vertebrates, in-
clude some of the most highly expressed ISGs. Different
species have varying complements of IFITs, but most mam-
mals possess IFIT1, IFIT1B, IFIT2, IFIT3 and IFIT5 (3).
IFITs typically contain multiple IFN-stimulated response
elements (ISREs) in their promoters (reviewed in 3) and are
also induced directly by IFN-regulatory factor 3 (5), down-
stream of initial PRR activation. Recently, phylogenetic
analysis revealed that rodents, including mice, have lost
IFIT1 but Ifit1b has undergone duplication twice (Ifit1b2
and Ifit1b3) and Ifit3 once (Ifit3b) (6).
IFITs are composed of sequential tetratricopeptide re-
peat (TPR) motifs that form globular N- and C-terminal
domains joined by a linker of variable flexibility (7–11).
TPR motifs are frequently involved in protein-protein in-
teractions and are commonly found in scaffolding proteins
(12). The crystal structures of IFIT1 and IFIT5 revealed
a positively charged pocket formed in the groove between
the N and C domains that interacts with single-stranded
RNA (8–10). IFIT1 RNA binding activity was first re-
ported by Pichlmair et al. (13) who identified proteins in
lysates from IFN stimulated cells that interacted with 5′-
ppp RNAs. Subsequently, we and others demonstrated that
IFIT1 tightly binds capped RNAs lacking methylation on
the first cap-proximal nucleotide (cap0) with low nanomo-
lar affinity (14–16). While similar positively charged tun-
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nels in IFIT1 and IFIT5 interact with the phosphate back-
bone of bound RNAs (8,9,14), only IFIT1 possesses a large
hydrophobic cavity at the rear of the tunnel that can ac-
commodate the cap structure (9). These findings support
a model whereby IFIT1 out-competes eukaryotic initiation
factor (eIF) 4E/4F for binding to cap0-mRNAs, thereby
inhibiting their translation. As host mRNAs are generally
methylated on the first or first and second bases (cap1 and
cap2, respectively), this selectivity offers a mechanism of
recognising and blocking translation of non-self RNAs.
The expression of IFIT1 imposes a strict requirement
on viruses that replicate in the cytoplasm and rely on
cap-dependent translation to evolve and maintain mecha-
nisms to avoid restriction by this ISG. For example, mem-
bers of the Flaviviridae and Coronaviridae families that
rely on cap-dependent translation to produce viral proteins
from their single-stranded positive-sense RNA genomes,
encode their own 2′-O-methyltransferases. Disruption of
methyltransferase activity increases susceptibility of the fla-
viviruses West Nile virus, Japanese encephalitis virus and
dengue virus (16–20) and the coronaviruses murine hep-
atitis virus and severe acute respiratory syndrome virus
(21,22) to IFIT1 restriction. Interestingly, enzymatically 2′-
O-methylated, capped mRNAs from parainfluenza virus
5 display differential translational sensitivity to IFIT1 in
vitro, while wild type middle east respiratory syndrome
coronavirus (MERS) replication was enhanced upon IFIT1
depletion suggesting that factors other than 5′ end methy-
lation can influence IFIT1 recognition (23,24). By contrast,
alphaviruses, such as the emerging human pathogen chikun-
gunya virus, also rely on cap-dependent translation but lack
a virally encoded 2′-O-methyltranferase, thus possessing vi-
ral mRNAs with a cap0 structure at the 5′ end (25). Recent
evidence suggests that stable secondary structure at the 5′
end of alphaviral genomes protects the viral RNAs from
IFIT1 restriction (26,27). IFIT1 may also affect translation
through interaction with eIF3 (28), while its direct binding
to the viral E1 protein restricts human papilloma virus repli-
cation (29).
An intriguing feature of IFITs is their propensity to homo
and heterooligomerize.Using pull-down experiments of dif-
ferentially tagged IFITs, Stawowczyk et al. (30) demon-
strated that IFIT2 could interact both with itself and with
IFIT1 and IFIT3 inHeLa cells. In the same study, an IFIT1,
IFIT2 and IFIT3 containing complex in HeLa cytoplasmic
lysates was also reported to migrate between 150–200 kDa
when analyzed by glycerol gradient sedimentation.Deletion
analysis identified the first four TPRs of IFIT2 as being
important for interaction with IFIT3 while the TPR(s) of
IFIT2 that promote interaction with IFIT1 could not be
elucidated (30). IFIT1 was later reported to interact with
IFIT2 or IFIT3 by size exclusion chromatography (SEC)
(13). The crystal structure of IFIT2 revealed it forms a sta-
ble, domain-swapped dimer, with TPRs of the N-terminal
domain exchanged between each monomer (7). Using na-
tive gel electrophoresis, we previously demonstrated IFIT1
and IFIT3 could homooligomerize (14), while a recently-
reported crystal structure of IFIT1 identified a motif in the
C terminus responsible for IFIT1 dimerisation (BioRxiv:
https://doi.org/10.1101/152850). However, despite consid-
erable evidence for IFIT oligomerisation, little is known
about how different IFITs interact and what impact this in-
teraction has on function.
Here, we have reconstituted different IFIT complexes
from individually purified proteins. We describe an assem-
bly pathway for the IFIT heterocomplex identifying a criti-
cal motif for IFIT1 and IFIT3 interaction. We also demon-
strate that IFIT1 expression is enhanced by the presence of
other IFIT proteins and that interaction with IFIT3 or a
heterocomplex of IFIT2 and IFIT3 enhances the cap0RNA
binding and translation inhibition activity of IFIT1. Our re-
sults provide a critical missing link between IFIT oligomer-
ization and function presenting a mechanistic framework
for understanding the role of IFITs in the host immune re-
sponse.
MATERIALS AND METHODS
Plasmids
For mammalian cell expression, sequences for human
IFIT1 (BC007091.1), IFIT2 (NM 001547.4), IFIT3
(NM 001549.5) and IFIT5 (BC025786.1) were PCR
amplified to include a 5′ Kozak sequence, 3′ FLAG tag
and 5′ BamHI and 3′ XhoI site to facilitate cloning into
pCDNA3.1. The plasmid for expression of IFIT1 in
Escherichia coli was previously described (10) and was used
as a template for site directed mutagenesis to generate the
mutant IFIT1 expression vectors. Sequences for IFIT2
and IFIT3 were PCR amplified to contain 5′ NdeI and
3′ XhoI restriction sites for cloning into pET28b (No-
vagen) producing a full-length protein with a thrombin
cleavable N-terminal 6-His tag. Mutant IFIT3 expres-
sion vectors were generated by site directed mutagenesis
using pCDNA3.1-IFIT3-FLAG or pET28b-IFIT3-His
as templates. For reporter RNA transcription, the firefly
luciferase reporter gene (Fluc) was PCR amplified using
primers containing the 5′ UTR and 3′ UTR sequences
of human -globin (NM 000518.4), including a 5′ T7
promotor and EcoRI and PstI sites to facilitate cloning
into pUC57. pUC57-ZIKV-Fluc was previously described
(31). The Nano luciferase reporter gene (Nanoluc) flanked
by the 5′ UTR and 3′ UTR sequences of the PE243 strain of
Zika virus (ZV), including a 5′ T7 promoter sequence, was
synthesized by Integrated DNA Technologies. EcoRI and
HindIII sites were included to allow cloning into pUC57.
Protein expression and purification
Recombinant IFITs were expressed in Rosetta 2 (DE3)
pLysS Escherichia coli (Novagen). Cells were grown to an
OD600 of approximately 1 in 2× TY media at 37◦C. Ex-
pression was induced by adding 1 mM isopropyl -D-1-
thiogalactopyranoside. The induced culture was incubated
at 22◦C for 16 h. Cells were harvested and lysed in a buffer
containing 20 mM Tris pH 7.5, 400 mM KCl, 5% glycerol,
1 mMDTT and 0.5 mM phenylmethylsulfonyl fluoride and
0.5 mg/ml lysozyme (from hen egg). IFITs were isolated by
affinity chromatography on Ni-NTA Agarose beads (Qia-
gen). IFIT1 and IFIT1 mutants were additionally purified
by FPLC on MonoQ (Q buffer: 20 mM Tris pH 7.5, 5%
glycerol, 1 mM DTT and 100–500 mM KCl), followed by
MonoS 5/50 GL (S buffer: 30 mM HEPES pH 7.5, 5%
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glycerol, 1 mM DTT and 100–500 mM KCl). IFIT2 and
IFIT3 were treated with thrombin (from bovine plasma).
IFIT2 and IFIT3 were further purified on MonoQ 5/50 (Q
buffer), followed by size exclusion chromatography (SEC)
on Superdex 200 increase 10/300GL orHiLoad 16/600 Su-
perdex 200 pg columns (SECbuffer: 20mMTris pH 7.5, 150
mMKCl and 1mMDTT). All FPLC columns are fromGE
Healthcare and all buffer reagents and enzymes were from
Sigma.
In vitro IFIT complex assembly
All complexes were assembled in SEC buffer.
IFIT1:IFIT2 and IFIT1:IFIT3––1 mg/ml of each pro-
tein was mixed and incubated for 1 h at 4 or 30◦C.
IFIT2:IFIT3––0.18 mg/ml of each protein was mixed
and incubated for 1 h at 37◦C and concentrated to 2
mg/ml. IFIT1:IFIT2:IFIT3 trimer––0.4 mg/ml of purified
IFIT2:IFIT3 complex and 0.2 mg/ml of IFIT1 were incu-
bated for 1 h at 30◦C. The complex was concentrated to 3
mg/ml. IFIT1:IFIT2:IFIT3 tetramer––0.4 mg/ml of puri-
fied IFIT2:IFIT3 complex and 0.4 mg/ml of IFIT1 were in-
cubated for 1 h at 30◦C. The complex was concentrated to 4
mg/ml. Complexes were concentrated using Amicon Ultra
0.5 ml 10 kDa molecular weight cut off filters (Millipore).
SEC analysis of mutant IFIT1 and IFIT3 complexes
Wild type or mutant IFIT1 and IFIT3 were combined as
described in IFIT complex assembly. 150 l of each assem-
bly reaction was injected on to a Superdex 200 Increase
10/300 GL column, at 0.3 ml/min flow rate and UV280
readings were monitored. Peak fractions were analyzed by
SDS-PAGE and Coomassie staining.
SEC-multi-angle light scatter (SEC-MALS)
Proteins/complexes were injected (100 l at the concentra-
tion described in IFIT complex assembly) onto an analytical
Superdex 200 Increase 10/300 gel filtration column. MALS
analysis was performed at room temperature, by inline mea-
surement of static light scattering (DAWN 8+, Wyatt Tech-
nology), differential refractive index (Optilab T-rEX, Wy-
att Technology), and 280 nm absorbance (Agilent 1260 UV,
Agilent Technologies) following SEC at a flow rate of 0.4
ml/min. Molecular masses were calculated using the AS-
TRA6 software package (Wyatt Technology).
Differential scanning fluorimetry
Differential scanning fluorimetry experiments to determine
the thermal stability of different IFIT complexes was per-
formed using a Viia7 Real-Time PCR system (Applied
Biosystems). In an optical 96-Well Reaction Plate (Applied
Biosystems 4366932), 1:500 Protein Thermal Shift dye (Life
Technologies, 4461146) was mixed with 0.1 mg/ml protein
in a final buffer composition of 20 mM HEPES pH 7.5,
150 mM KOAc, 2.5 mM MgOAc, 5% glycerol and 1 mM
DTT in a final volume of 20 l. Emission from quadrupli-
cate samples was measured at 623 nm while ramping from
25 to 95◦C stepwise at a rate of 1◦C per 20 s. To determine
Tm, data were analyzed by non-linear regression using the
Boltzmann equation y = LL + (UL – LL)/(1 + exp(Tm –
x)/a) where LL and UL are the minimum and maximum
fluorescence intensities respectively (32).
In vitro transcription
pUC57-globin-Fluc was linearized with FspI. pUC57-
ZIKV-Fluc and pUC57-ZIKV-Nanoluc were linearized
with HindIII. RNA was transcribed using recombinant T7
polymerase at a final concentration of 50 ng/l in tran-
scription buffer (40 mM HEPES pH 7.5, 32 mM MgOAc,
40 mM DTT, 2 mM Spermidine, 10 mM NTPs, 0.2 U/l
RNaseOUT (Invitrogen)) for 2–4 h at 37◦C. RNA was pu-
rified by DNaseI treatment, acidic phenol extraction and
ethanol precipitation. Residual nucleotides were removed
using Illustra MicroSpin G-50 columns (GE Healthcare).
RNA was capped using the ScriptCap and ScriptCap 2′-O-
methyltransferase system (CellScript).
In vitro translation
IFIT proteins or complexes were diluted in bovine serum
albumin (BSA) diluent buffer (0.5 mg/ml BSA, 20 mMTris
pH 7.5, 160 mM KCl, 5% glycerol, 2 mM DTT, 1 U/l
RNaseOUT), and incubated with 4 nM reporter RNA for
15 min at 37◦C to allow RNA binding. In vitro translation
was performed using the Flexi Rabbit Reticulocyte Lysate
(RRL) System (Promega) for 90 min at 30◦C. Reactions
were terminated by incubation on ice, followed by addition
of 50 volumes of passive lysis buffer (Promega) before lu-
ciferase signal was measured by GloMax (Promega). Lu-
ciferase values were normalized to the diluent buffer-only
control for each experiment.
Western blotting
Proteins were resolved by 12.5% SDS-PAGE and trans-
ferred to 0.45 m nitrocellulose membrane. Antibodies
used were anti-FLAG M2-Peroxidase (A8592, Sigma),
anti-FLAG M2 (F3165, Sigma), anti-IFIT1 (PA3-848,
ThermoFisher), anti-IFIT2 (12604-1-AP, Proteintech),
anti-IFIT3 (PA5-22230, ThermoFisher), anti-GAPDH
(AM4300, ThermoFisher) and anti-penta-His (34660,
Qiagen). For pull-down experiments FLAG-tagged pro-
teins were detected by chemiluminescence using Westar
Supernova substrate (Cyanagen) and visualized on Su-
per RX-N film (Fujifilm). For all other western blot
experiments an Odyssey CLx Imaging System (Li-Cor)
was used. To normalize recombinant IFIT proteins and
complexes, membranes were probed with anti-penta-His
and quantified using ImageJ.
Analysis of the IFIT1-mRNA interaction by inhibition of
primer extension (toeprinting)
IFIT1/mRNA interaction was performed essentially as de-
scribed previously (14) with minor modifications. Cap0-ZV
or cap0--globin reporter mRNAs (1 nM) were incubated
with IFIT1 or IFIT1 containing complexes (at concentra-
tions indicated in figures) for 10 min at 37◦C in 20 l re-
actions containing 20 mM Tris pH 7.5, 100 mM KCl, 2.5
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mM MgCl2, 1 mM ATP, 0.2 mM GTP, 1 mM DTT, 0.25
mM spermidine and 0.5 mg/ml BSA. IFIT1/mRNA in-
teraction was monitored by inhibition of primer extension
using avian myeloblastosis virus reverse transcriptase (2.5
U) (Promega) and a 32P-labeled primer in the presence of
4 mM MgCl2 and 0.5 mM dNTPs. Full length and trun-
cated cDNA products were separated in a denaturing 6%
acrylamide gel and detected by autoradiography using an
FLA7000 Typhoon Scanner (GE). Analysis was performed
using Image-Quant TL.
HEK293T transfection
HEK293T cells (1 × 106) were transfected with wild type
or mutant IFIT1, IFIT2 and/or IFIT3 FLAG-tagged ex-
pression constructs as indicated in the text using Lipofec-
tamine 2000 (ThermoFisher) using the manufacturers stan-
dard protocol. After 24 h cells were harvested, and protein
expression analyzed by western blotting.
RNA transfection
HEK293T cells (1 × 106) were transfected with wild type
IFIT1 and wild type or mutant IFIT3 expression plasmids
as indicated in the text using Lipofectamine 2000 (Ther-
moFisher). After 24 h, cells were trypsinized and 1.5 × 105
cells per well were plated into a 48-well plate, in duplicate.
After 4 h, cells were washed intoOpti-MEMmedium (Ther-
mofisher) and transfected with 100 fmol each cap0-ZIKV-
Fluc and cap1-ZIKV-Nanoluc RNA using Lipofectamine
2000, or untreated (mock), for 6 h. Cells were harvested in
passive lysis buffer. Fluc signal was detected as described
above. Nanoluc signal was detected using the Nano-Glo lu-
ciferase assay system (Promega). Plasmid transfection was
performed in triplicate and RNA transfections in duplicate.
Luciferase values are expressed as a ratio of Nanoluc (cap1)
over Fluc (cap0), normalized to the empty vector control.
Stable isotope labeling with amino acids in cell culture and
immunoprecipitation
HEK293T cells were cultured in Arg/Lys-free DMEM,
supplemented with light (R0K0), medium (R6K4) or heavy
(R10K8) amino acids, as described (33). 1 × 107 cells were
transfected with 10 g plasmid DNA using Lipofectamine
2000 (ThermoFisher). After 24 h, media was replaced to
contain 1000 U/ml human interferon -2a (Roferon-A,
Roche) for a further 16 h. Cells were harvested in lysis buffer
(50 mM Tris pH 7.5, 150 mMNaCl, 1 mM EDTA, 1% Tri-
ton X100) containing 1:200 Protease Inhibitor Cocktail Set
III (Merck) and 1:200 Benzonase nuclease (Sigma-Aldrich).
Lysates were normalized to 3 mg/ml of protein before incu-
bation with anti-FLAG-M2 affinity gel (Sigma) at 4◦C for
18 h. Beads were washed three times in Tris-buffered saline,
then resuspended in 2× SDS-sample buffer (Invitrogen) and
boiled for 5 min to elute bound proteins.
LC–MS/MS and sample preparation
Following immunoprecipitation, the combined samples
were subjected to SDS-PAGE electrophoresis on a precast
gel, and extracted as a single band for in-gel trypsinisa-
tion. The resulting peptides were fractionated using an Ul-
timate 3000 nanoHPLC system in line with an Orbitrap
Fusion Tribrid mass spectrometer (Thermo Scientific). In
brief, peptides in 1% (vol/vol) formic acid were injected
onto an Acclaim PepMap C18 nano-trap column (Thermo
Scientific). After washing with 0.5% (vol/vol) acetonitrile
0.1% (vol/vol) formic acid, peptides were resolved on a 250
mm× 75mAcclaimPepMapC18 reverse phase analytical
column (Thermo Scientific) over a 150 min organic gradi-
ent, using seven gradient segments (1–6% solvent B over 1
min, 6–15% B over 58 min, 15–32% B over 58 min, 32–40%
B over 5 min, 40–90% B over 1 min, held at 90% B for 6 min
and then reduced to 1% B over 1 min) with a flow rate of
300 nl min−1. Solvent A was 0.1% formic acid and Solvent
B was aqueous 80% acetonitrile in 0.1% formic acid. Pep-
tides were ionized by nano-electrospray ionization at 2.0 kV
using a stainless steel emitter with an internal diameter of
30 m (Thermo Scientific) and a capillary temperature of
275◦C.
All spectra were acquired using an Orbitrap Fusion Trib-
rid mass spectrometer controlled by Xcalibur 2.1 software
(Thermo Scientific) and operated in data-dependent acqui-
sition mode. FTMS1 spectra were collected at a resolution
of 120 000 over a scan range (m/z) of 350–1550, with an au-
tomatic gain control (AGC) target of 300 000 and a max in-
jection time of 100 ms. Precursors were filtered using an In-
tensity Range of 1E4 to 1E20 and according to charge state
(to include charge states 2–6) and with monoisotopic pre-
cursor selection. Previously interrogated precursors were
excluded using a dynamic window (40 s ±10 ppm). The
MS2 precursors were isolated with a quadrupole mass fil-
ter set to a width of 1.4 m/z. ITMS2 spectra were collected
with an AGC target of 20 000, max injection time of 40 ms
and CID collision energy of 35%.
Mass spectrometry data analysis
The raw data files were processed and quantified using
MaxQuant v1.5.7.4 (34) and searched against the Uniprot
Human database (70 550 entries, dated 19 September 2016)
using the built-in Andromeda search engine. Peptide pre-
cursor mass tolerance was set a 4.5 ppm, and MS/MS
tolerance was set at 0.5 Da. Search criteria included car-
baminomethylation of Cys as a fixed modification. Oxida-
tion of Met and N-terminal acetylation were selected as
variable modifications. Quantification was based on Light
(Arg 0, Lys 0), Medium (Arg 6, Lys 4), and Heavy (Arg 10,
Lys 8) SILAC labels. Searches were performed with tryptic
digestion, a minimum peptide length of seven amino acids,
and a maximum of two missed cleavages were allowed. The
reverse database search option was enabled and the maxi-
mum false discovery rate for both peptide and protein iden-
tifications was set to 0.01. Quantitation was performed us-
ing a mass precision of 2 ppm. The full MaxQuant output
is provided as part of PRIDE submission PXD007584 per-
mitting viewing of annotated spectra inMaxQuant v1.5.7.4.
Downstream analysis was accomplished in the Perseus soft-
ware (35). Contaminants and reverse database hits were re-
moved, and protein ratios were log2-transformed. Proteins
were considered to represent putative interaction partners
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if they showed a significant (t-test, P < 0.05) increase in
their abundance compared with the control pulldown and
had to have been identified in at least two of the three
replicates. Full proteomics data sets are available on Pro-
teomeXchange via the PRIDE repository with the identifier
PXD007584.
Protein structure modeling and analysis
Protein structure analysis and generation of protein struc-
ture images was performed using PyMOL (The PyMOL
Molecular Graphics System, Version 2.0 Schro¨dinger,
LLC). The IFIT3 model was generated by submitting the
IFIT3 amino acid sequence to the Swiss Model server. The
crystal structure of the IFIT2 domain-swapped homodimer
(PDB:4G1T) was used as a template for model generation.
The electrostatic surface potential of IFIT2 and the IFIT3
model were analyzed using PDB2PQR and APBS software
(36–38).
RESULTS
IFIT1 co-precipitates IFIT2 and IFIT3 independently of
RNA association
IFIT1 was originally identified as an RNA binding pro-
tein after being precipitated by 5′-ppp RNA from lysates
of IFN stimulated HEK293 cells. IFIT2 and IFIT3, as well
as several well-characterized RNA binding proteins, co-
precipitated with IFIT1 (13). We used SILAC proteomics
to examine if IFIT1 could interact directly with IFIT2 and
IFIT3 in nuclease treated lysates from IFN-stimulated cells.
HEK293T cells were passaged in differentially isotopically
labeled media and transfected with either a plasmid ex-
pressing FLAG-tagged IFIT1, FLAG-tagged IFIT5 (pre-
viously reported not to interact with other IFITs (13,30)),
or an empty vector control. Twenty four hours after trans-
fection the cells were treated with IFN- and incubated for
a further 16 h. Preparation of nuclease treated cell lysates
and pull-down experiments are described in Materials and
Methods. Consistent with previous reports (39), IFIT1 was
poorly overexpressed while IFIT5 was strongly expressed
(Supplementary Figure S1). However, as shown in Figure
1A, IFIT2 and IFIT3 co-precipitated with FLAG-tagged
IFIT1, while FLAG-tagged IFIT5 did not precipitate other
IFIT family members (Figure 1B). The full SILAC data
set is available on the PRIDE server. These results inde-
pendently confirm the interaction of IFIT1, 2 and 3 in
IFN-stimulated cell lysates and further demonstrate that
this interaction ismaintained after nuclease treatment. Both
IFIT2 and IFIT3 were enriched to a similar extent in the
IFIT1 pull downs (Figure 1A).
IFIT1:IFIT2:IFIT3 hetero-complexes can be reconstituted
from bacterially expressed proteins
To investigate human IFIT family oligomerisation and ex-
amine the influence of interaction with IFIT2 and IFIT3 on
IFIT1 mRNA cap0 binding activity we reconstituted the
IFIT1:IFIT2:IFIT3 hetero-complex in vitro. To this end,
His-tagged IFIT1, IFIT2 and IFIT3 were individually ex-
pressed in bacteria and purified as described in Materials
and Methods. The His-tag was removed from IFIT2 and
IFIT3 but retained on IFIT1 for later detection. Each pro-
tein was subjected to size exclusion chromatography with
multi angle light scattering (SEC-MALS) to analyze IFIT
assembly. SEC-MALS reveals themolecularmass of species
eluting at different volumes from a size exclusion column
providing information about the oligomeric state of these
species. Varying concentrations of IFIT were analyzed by
SEC-MALS and, consistent with a recent report (BioRxiv:
https://doi.org/10.1101/152850), IFIT1 oligomerized in a
concentration-dependent manner (Supplementary Figure
S2A). In contrast, IFIT2 eluted as two species correspond-
ing to a stable dimer or tetramer (Supplementary Figure
S2B). Surprisingly, the IFIT2 dimer had a similar elution
volume to the lowest concentration of IFIT1 examined.
This demonstrates the importance of using the SEC-MALS
technique which directly determines the mass of particles
in solution from their Rayleigh scattering, instead of rely-
ing on the elution volumes of molecular weight standards
during SEC to infer oligomeric state. When analyzed alone,
IFIT3 also eluted as amostly dimeric species, with a smaller
peak corresponding to a monomer (Supplementary Figure
S2C).
We next examined the oligomeric status of complexes
containing mixtures of the individually purified IFIT pro-
teins. IFIT1 and IFIT3 formed a stable complex that eluted
with a molecular mass of 221 kDa (Figure 2A, peak a).
Analysis of the protein peaks by SDS-PAGE shows that
IFIT1 and IFIT3 are equimolar, indicating that this com-
plex represents stable IFIT1:IFIT3 tetramers. A later elut-
ing species likely corresponding to IFIT1:IFIT3 dimers (123
kDa) is also evident (Figure 2A, peak b). To determine
the relative stabilities of IFIT1 alone or complexed with
IFIT3we examined IFIT1 and the IFIT1:IFIT3 heterocom-
plex using differential scanning fluorimetry. Using this ap-
proach, protein unfolding is monitored by measuring the
signal from a dye that fluoresces in hydrophobic environ-
ments at increasing temperature. More stable proteins un-
fold at higher temperatures than less stable proteins. Un-
folding exposes hydrophobic regions of the protein making
them more accessible to the dye. As seen in Figure 2B the
IFIT1:IFIT3 complex melts at a higher temperature than
either IFIT1 or IFIT3 in isolation indicating that the com-
plex is indeed more stable than either protein alone. The
IFIT1:IFIT2 complex was less defined than IFIT1:IFIT3
and eluted as multiple species ranging from 148 to >234
kDa as measured by SEC-MALS (Supplementary Figure
S2D). Interestingly this interaction was only observed when
the proteins were incubated at 30◦C prior to SEC-MALS
analysis. When combined at 4◦C prior to SEC analysis only
a very weak interaction between IFIT1 and IFIT2 was ob-
served (Supplementary Figure S2E).
Because IFIT2 and IFIT3 were enriched to a similar de-
gree in our IFIT1 pull down SILAC experiments we hy-
pothesized that IFIT1 could interact with a heterodimer
of IFIT2 and IFIT3. We therefore examined if IFIT2 and
IFIT3 formed a stable complex. Equal amounts of IFIT2
and IFIT3 were mixed and incubated at 4◦C for 1 h. When
analyzed by SEC-MALS twopeaks corresponding to IFIT2
and IFIT3 homodimers were clearly separated (Figure 2C,
grey dotted line). In contrast, when IFIT2 and IFIT3 were
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Figure 1. Interaction between IFIT1, IFIT2 and IFIT3 occurs independently of bound RNA. Volcano plots of SILAC proteomics data showing statistical
analysis of proteins that immuno-precipitated with (A) FLAG-tagged IFIT1 or (B) FLAG-tagged IFIT5 following nuclease treatment of IFN-stimulated
cell lysates. Data represent the analysis of three biological replicate experiments, and the mean log2-fold change and t-test P-values plotted represent the
combined data from these three replicates. Data points corresponding to IFIT family members are colored and labeled.
instead incubated at 37◦C for 1 hour an IFIT2:IFIT3 het-
erodimer was formed (Figure 2C, black dashed line). The
molecular weight of the eluting species (110 kDa) and anal-
ysis by SDS-PAGE (gel inset) are consistent with this com-
plex representing an IFIT2:IFIT3 heterodimer. As evident
in Supplementary Figure S2F, when peak fractions were re-
analyzed by SEC-MALS there was no observed dissocia-
tion of the complex into constituent components, confirm-
ing that the IFIT2:IFIT3 complex is stable. To determine
the relative stabilities of the different dimeric complexes, we
examined IFIT2, IFIT3 and the IFIT2:IFIT3 heterodimer
using differential scanning fluorimetry. Figure 2D shows the
thermal melt curves for IFIT2 and IFIT3 homodimers and
the IFIT2:IFIT3 heterodimer. Of the three sets of dimers
IFIT3 was the least stable as it displays the lowest melting
temperature while IFIT2:IFIT3 was more stable than either
homodimer.
Having successfully formed a stable IFIT2:IFIT3
complex, we attempted to reconstitute the full
IFIT1:IFIT2:IFIT3 heterotrimeric complex. An equimolar
ratio of IFIT1 was incubated with the purified (preformed)
IFIT2:IFIT3 heterodimeric complex. Most of the IFIT1
was incorporated into a larger complex that eluted with
a molecular mass of 165 kDa corresponding to a trimer
(Figure 2E). Analysis of this complex by SDS-PAGE
(gel inset) reveals that it contains equimolar amounts
of IFIT1, IFIT2 and IFIT3. Finally, we incubated the
IFIT2:IFIT3 heterodimer with a two-fold molar excess
of IFIT1 at 30◦C for 1 hour. Analysis by SEC-MALS
reveals a clear shift of the heterotrimeric complex to a
heterotetrameric complex with a molecular mass of 236
kDa (Supplementary Figure S2G). SDS-PAGE analysis of
this complex reveals a molar excess of IFIT1 over IFIT2
and IFIT3 indicating that the heterotetrameric complex
consists of two IFIT1 molecules to one molecule each of
IFIT2 and 3 (compare gel insets in Figure 2E and Sup-
plementary Figure S2G). The ability to form this complex
in vitro from purified components demonstrates that the
complex can assemble independently of IFN stimulation.
The IFIT1:IFIT2:IFIT3 heterotetramer precipitated with
time so the IFIT1:IFIT2:IFIT3 heterotrimer was used for
further experiments. We examined the relative stability
of each of our new complexes by differential scanning
fluorimetry as shown in Figure 2F. The thermal melting
curves for IFIT1, IFIT2 and the IFIT1:IFIT2 complex
were nearly identical indicating that each of these are
more stable than IFIT3 alone (compare Figure 2B and F)
whereas IFIT1:IFIT3 and IFIT1:IFIT2:IFIT3 were the
most stable complexes examined.
IFIT3 and IFIT2:IFIT3 stimulate the cap0-RNA translation
inhibition activity of IFIT1
To investigate the impact of hetero-oligomerisation on the
ability of IFIT1 to inhibit cap0-dependent translation we
used a similar approach to that previously described by
Young et al. (23). In vitro transcribed mRNAs comprising a
firefly luciferase (Fluc) reporter flanked by either the ZV or
human-globin 5′ and 3′ untranslated regions (UTRs) were
post-transcriptionally capped as described in the Materials
andMethods. As described in the Introduction, flaviviruses
lacking 2′-O-methylation are inhibited by IFN in an IFIT1-
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Figure 2. In vitro reconstitution of IFIT oligomeric assemblies. (A, C and E) Indicated IFIT complexes were assembled and analyzed by SEC-MALS as
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IFIT1, IFIT2 and IFIT3 on the protein gels is indicated. (B,D and F) Differential scanning fluorimetry analysis of the indicated complexes was performed
as described in the Materials and Methods.
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Table 1. Comparison of translation inhibition and cap0 mRNA binding kinetics
Complex/RNA
IC50† (nM IFIT1
in RRL)
P-value (IFIT1 vs
complex)
RNA binding
(K1/2, app, nM) Hill number
IFIT1/cap0--globin 71 ± 5.9 - 40 ± 1.2 2.8 ± 0.2
IFIT1:IFIT2/cap0--globin 58 ± 5.3 0.2798 - -
IFIT1:IFIT3/cap0--globin 24 ± 1.2 <0.0001 19 ± 0.8 2.5 ± 0.2
IFIT1:IFIT2:IFIT3/cap0--globin 45 ± 2.9 <0.0001 19 ± 0.7 2.0 ± 0.1
IFIT1/cap0-ZV 112 ± 7.6 - 69 ± 1.8 3.5 ± 0.3
IFIT1:IFIT3/cap0-ZV 54 ± 3.5 <0.0001 29 ± 1.1 4.1 ± 0.6
IFIT1:IFIT2:IFIT3/cap0-ZV 46 ± 2.6 <0.0001 58 ± 2.3 3.1 ± 0.3
Values are from data presented in Figures 3 and 4. Details of the analysis performed are included in the corresponding figure legends.
†IC50 values are the concentration of IFIT complexes that reduce the reporter translation by 50% ± standard error.
dependentmanner. As such the cap0 version of this reporter
is a representative mRNA that is inhibited by IFIT1. The
-globin reporter was examined as it has very weak sec-
ondary structure and a previous study has suggested that
IFIT1 binding may be affected by both 5′ end methylation
state and RNA secondary structure (9). Schematics of the
two constructs are shown in Figure 3A. ThesemRNAswere
incubated with different IFIT heterocomplexes before addi-
tion of rabbit reticulocyte lysate (RRL). Advantages of the
RRL system for this analysis are that the impact of differ-
ent IFIT complexes on translation can be monitored inde-
pendently of other changes occurring due to IFN stimula-
tion and that the effects of defined amounts of each complex
can be examined. We also previously used translation fac-
tors purified from RRL for the initial demonstration that
IFIT translation regulation was affected by the cap struc-
ture of the mRNA 5′ end (14). A well-known restriction of
the RRL system is that it does not completely recapitulate
the cap/polyA synergy of translation initiation (40). How-
ever, ZV, like other flaviviruses that utilize cap-dependent
translation, do not possess 3′ polyA tails and do not require
circularization for translation (41). Translation was quanti-
fied by measuring the luminescence from the Fluc reporter.
The amount of IFIT1 added was equalized by western blot-
ting against the His-tag on the purified IFIT1 in each com-
plex. The upper panel of Figure 3B shows an SDS-PAGE
analysis of the protein complexes used in these experiments
while the lower panel shows an anti-His-tag western blot of
the same complexes. The linearity of the western blot signal
to protein concentration was confirmed as shown in Sup-
plementary Figure S3.
IFIT1 inhibited translation of the cap0--globin Fluc re-
porter in a concentration-dependent manner (Figure 3C).
Pre-incubation of IFIT1 and IFIT2 had no detectable im-
pact on the inhibition of translation of the cap0--globin
Fluc reporter and so was not examined further. In con-
trast, complexing with IFIT3 reproducibly decreased the
concentration of IFIT1 required to cause 50% inhibition
of the same reporter (Figure 3C). The IC50 values derived
from the experiments shown in Figure 3 are displayed in Ta-
ble 1. IFIT1 inhibited translation of the cap0-ZV reporter
less than the -globin reporter overall but complexing with
IFIT3 again enhanced IFIT1’s translation inhibitory effect
(Figure 3D). As can be seen in Figure 3E and F, stimula-
tion of IFIT1 translation inhibition was reproducibly ob-
served in the context of the IFIT1:IFIT2:IFIT3 complex.
The average volume of HeLa cells was previously reported
as 2.6 × 103 m3 (42), while 2.4 × 106 copies of IFIT1
were estimated to be present after IFN stimulation of HeLa
cells (13). This would mean IFIT1 is present at an effec-
tive concentration of ≥1.5 M making the concentrations
used in our assays physiologically relevant. Reporter mR-
NAs bearing cap1 were also examined (Figure 3C–F and
Supplementary Figure S4) but showed much greater resis-
tance to IFIT1 inhibition. The ability to observe this∼two-
fold decrease in the IC50 values for the inhibition of trans-
lation by IFIT1 in the presence of IFIT3 or IFIT2:IFIT3
in this system is significant, as RRL is very efficient in sup-
porting cap-dependent translation as evidenced by the lack
of cap/polyA synergy described above. Our results clearly
implicate the structure present at the 5′ end of a mRNA,
as well as the methylation state, as an important determi-
nant of susceptibility to IFIT1 restriction and that interac-
tion with IFIT3 or IFIT2:IFIT3 can also influence this.
IFIT3 and IFIT2:IFIT3 enhance cap0-RNA binding by
IFIT1
We and others have previously demonstrated that IFIT1
binds preferentially to mRNA with a cap0 at the 5′ end
(14,15). Using our purified complexes, we next examined
if the interaction of IFIT1 with cap0 mRNA was altered
when part of a larger IFIT1:IFIT3 or IFIT1:IFIT2:IFIT3
complex. We used a primer extension inhibition assay to
monitor the IFIT1/cap0 mRNA interaction as previously
described (14). An advantage of this technique over other
methods to analyze protein–RNA interactions, such as elec-
trophoretic mobility shift assays, is that the primer exten-
sion reaction is performed in equilibrium binding condi-
tions. IFIT1 alone or as part of an IFIT heterocomplex was
incubated with the in vitro transcribed and capped model
-globin and ZV mRNAs prior to the addition of a radio-
labeled primer that binds within the Fluc mRNA sequence.
A reverse transcription reaction was performed in which
a full-length cDNA is produced in the absence of IFIT1,
whereas a 7 nucleotide truncated cDNA, corresponding to
the length of the IFIT1 RNA-binding surface, is produced
in the presence of IFIT1 (14). The cDNA products are sub-
sequently separated by denaturing PAGE and detected by
autoradiography. IFIT protein complexes shown in Figure
3B were used in the binding reactions. Representative au-
toradiographs are shown in Figure 4A. Quantification of
the cDNA products was performed as described in the Ma-
terials andMethods and the binding curves shown in Figure
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Figure 3. IFIT3 and IFIT2:IFIT3 enhance IFIT1 cap0 translation inhibition in vitro. (A) Schematic representation of the cap0-mRNAs used in in vitro
translation assays in RRL. (B) IFIT1 containing complexes included in in vitro translation assays.Upper panel, Coomassie stained SDS-PAGE gel analysis
of individually purified and complexed IFITs. Lower panel, analysis of the same samples as in the upper panel by western blotting against the His-tag. Note,
the His-tag was removed from IFIT2 and IFIT3 but not IFIT1 during purification. (C–F) Luciferase activity from RRL incubated with cap0--globin
Fluc RNA (C, E) or cap0-ZV Fluc RNA (D, F) in the presence of increasing concentrations of IFIT1 or IFIT1 containing complexes as indicated. In each
panel (C-F) the effect of IFIT1 on the cap1 versions of the model RNAs is also shown. Data are normalized to the luciferase activity in the absence of
IFITs and shown as the mean ± the standard error of three separate experiments. To calculate the IFIT complex concentration at which translation was
inhibited by 50% data were fitted to [Inhibitor] versus normalized response curve (Y = 100/(1 + (XHillSlope)/(IC50HillSlope) using the least squares method
in GraphPad Prism. IFIT concentrations at which reporter translation was 50% inhibited are reported as IC50 values in Table 1.
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Figure 4. IFIT3 containing complexes stabilize IFIT1 binding to cap0 RNA. (A) Toeprinting analysis of the interaction of IFIT1 and IFIT1 containing
complexes with cap0 RNA. The full-length and 7 nucleotide (nt) truncated cDNA product produced by IFIT1 binding are indicated. Protein complexes
and RNAs are the same as those used in Figure 3. (B, C) Graphs represent fraction of RNA bound by IFIT1 and IFIT1 containing complexes at varying
IFIT1 concentrations. Curves representative of three separate experiments were fitted using the nonlinear Hill equation, Fraction[bound] = [IFIT1]h •
Fraction[bound]max/([IFIT1]h + Kh1/2,app) from data where [IFIT1] was ≥ 10 • [mRNA]. K1/2,app and Hill coefficients (h) are listed in Table 1.
4B and C show the fraction of RNA bound at varying IFIT
concentrations.
As previously reported (14), IFIT1 binds cap0--globin
mRNA with very high affinity. The binding constants for
the experiments shown in Figure 4 are presented in Table
1. Complexing with IFIT3 or the IFIT2:IFIT3 heterodimer
enhances binding of IFIT1 to this mRNA. IFIT1 hetero-
complexing also has the effect of saturating the binding
on the mRNA as evident in the autoradiograms. This ef-
fect was even more pronounced when the cap0-ZV reporter
was analyzed. On this more structured model viral RNA
IFIT1 binding only reached 60% saturation. When com-
plexed with IFIT3, IFIT1 bound the ZV reporter with 2-
fold higher affinity, similar to the effect observed for the
cap0--globin mRNA. In contrast, the calculated K1/2, app
for the IFIT1:IFIT2:IFIT3 complex binding to the cap0-
ZV reporter was only marginally lower than that for IFIT1
alone. However, again as is clear from the autoradiograms,
addition of IFIT3 or the IFIT2:IFIT3 heterodimer led to
saturation of RNA binding. It is not yet known how IFIT3
promotes IFIT1-cap0 binding, however, based on our in
vitro RNA binding experiments we speculate that IFIT3
decreases the IFIT1 off rate, enhancing its ability to block
eIF4F recruitment. This is potentially particularly impor-
tant when IFIT1 is binding mRNA with highly structured
5′ ends as our translation inhibition results in Figure 3 sug-
gest. As IFIT1:IFIT3 is predominantly a stable tetramer
with two copies of each protein and since complexing with
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IFIT3 has a more noticeable effect on the apparent affinity
of IFIT1 for cap0 mRNA, we conclude that IFIT3 and not
IFIT2 in the IFIT2:IFIT3 complex is responsible for the ob-
served effects. In all cases, and similar to our previous find-
ings (14), the Hill coefficient was greater than 1, indicating
a degree of cooperativity in IFIT1 cap0-mRNA binding.
IFIT1 and IFIT3 interact through a C-terminal motif
Our data reveal that IFIT3 or the IFIT2:IFIT3 het-
erodimer can stimulate non-self mRNA binding and trans-
lation inhibition by IFIT1. We next sought to iden-
tify how IFIT1 and IFIT3 interact. Murine Ifit3, which
does not precipitate with murine Ifit1b1 (15), has a
large deletion at the C terminus (Supplementary Figure
S5) when compared to human IFIT3. As a result of
this deletion, mouse Ifit3 lacks a YxxxL structural mo-
tif present in both human IFIT3 and IFIT1 (Figure 5A
and B) recently reported to promote IFIT1 concentration-
dependent dimerisation (BioRxiv: https://doi.org/10.1101/
152850). Our SEC-MALS and differential scanning flu-
orimetry analysis demonstrates that the IFIT1:IFIT3 in-
teraction is more stable than the IFIT1:IFIT1 interaction
(compare Figure 2A and Supplementary Figure S2A). We
therefore hypothesized that the proposed IFIT1 dimeriza-
tion motif is the site of interaction between IFIT1 and
IFIT3.
Based on the IFIT1 dimer crystal structure (PDB:
5W5H) we generated three IFIT1 mutants, Y460E and
L464E single mutants and a Y460E/L464E double mutant.
All mutants expressed and purified similarly to thewild type
protein and eluted as monomeric species during SEC (Fig-
ure 5C) consistent with disruption of IFIT1 homodimer-
ization as previously reported (BioRxiv: https://doi.org/10.
1101/152850). However, the L464E substitution had only a
modest effect on the interaction of IFIT1 with IFIT3 (Fig-
ure 5D). The Y460E substitution destabilizes IFIT1:IFIT3
oligomerization to a greater extent than the L464E substi-
tution (Figure 5E), but the double mutation Y460E/L464E
completely abrogates the IFIT1-IFIT3 interaction (Figure
5F). We also confirmed that the corresponding YxxxL mo-
tif on IFIT3 is responsible for the interaction with IFIT1
(Supplementary Figure S6).Mutation of thismotif however
did not affect IFIT3 homodimerization.
Disruption of dimerisation was previously reported
not to affect the translation inhibition activity of IFIT1
(BioRxiv: https://doi.org/10.1101/152850 and Figure 5G,
white bars). Therefore, we examined what impact mutations
in the YxxxL motif had on the ability of IFIT3 to stim-
ulate IFIT1 translation inhibition activity. IFIT1 mutants
were combined with IFIT3, reporter mRNA and RRL as
described in Materials and Methods and luminescence was
measured (Figure 5G). At 40 nM IFIT1, YxxxL motif mu-
tants displayed similar translation inhibition to wild type
IFIT1. IFIT3 significantly enhanced translation inhibition
of both wild type IFIT1 and the IFIT1-L464E mutant. In
contrast, IFIT3 did not stimulate translation inhibition of
either the IFIT1-Y460E mutant or the L464E/Y460E dou-
ble mutant.
IFIT2 and IFIT3 stabilize IFIT1 expression in cells
After confirming that reconstituted heterocomplexes are
more stable than the individual IFIT proteins in vitrowe ex-
amined the impact of IFIT complexing in a cell-based sys-
tem. HEK293T cells were transfected with either FLAG-
tagged IFIT1 alone or along with increasing amounts of a
plasmid encoding IFIT2 or IFIT3. The amount of FLAG-
tagged IFIT1 plasmid used produces a similar level of IFIT1
expression as detected after 24 h treatment with IFN-
(Supplementary Figure S7A). The presence of IFIT3 but
not IFIT2 dramatically stabilized the expression of IFIT1
(Figure 6A and B). As shown in Figure 6C, the stabiliza-
tion is dependent on the integrity of the YxxxL motif. In-
terestingly, mutation of the YxxxL motif in IFIT1 causes a
small but reproducible increase in IFIT1 expression in the
absence of any other IFITs (compare lanes 1 and 3 in Fig-
ure 6C). Since FLAG-tagged IFIT1 and IFIT2 could not
be separated by SDS-PAGE we used anti-IFIT1 to detect
protein expression. IFIT2 expression in these samples was
confirmed as shown in Supplementary Figure S7B.
Finally, we examined whether IFIT3 could enhance
IFIT1 activity in cells. HEK293T cells were transfected
with IFIT1 alone or co-transfected with either wild type or
Y438E/L442E mutant IFIT3, which cannot bind to IFIT1
(Supplementary Figure S6). After 24 h, in vitro transcribed
and capped mRNAs comprising the Fluc or Nanoluc re-
porter genes shown in Figure 6D flanked by the ZV 5′ and
3′ UTRs were transfected into the IFIT-expressing cells, as
described in Materials and Methods. The ZV Fluc mRNA
is the same as that used in the in vitro translation inhibi-
tion assays in Figure 3. The ZVNanolucmRNA is identical
to this reporter but expresses a nano luciferase gene rather
than a firefly luciferase gene. As addition of cap1 to the
ZV genome renders it resistant to IFIT1 inhibition (Supple-
mentary Figure S4), translation from the cap1 ZV Nanoluc
reporter serves as an internal control for RNA transfec-
tion efficiency. Translation was quantified by measuring lu-
minescence from the Fluc or Nanoluc reporters and ex-
pressed as a ratio of Fluc(cap0)/Nanoluc(cap1) in Figure
6D. IFIT1 alone caused a 20% reduction in cap0 RNA
translation compared to empty vector transfected cells. Co-
expression with wild type IFIT3 resulted in a two-fold en-
hancement of this inhibition. In contrast, co-expression
with the Y438E/L442E mutant IFIT3 that does not bind
wild type IFIT1 had no effect on IFIT1-mediated transla-
tion inhibition. These in cell experiments confirm an impor-
tant role for IFIT3 in promoting the full antiviral effects of
IFIT1.
DISCUSSION
The IFIT family of ISGs are among the most highly up-
regulated proteins during the cellular response to viral in-
fection and, while a role for IFITs in regulating translation
has long been postulated, the mechanisms by which these
proteins function are only recently being revealed. Here, we
have presented, to our knowledge, the first in vitro reconsti-
tution of the IFIT1:IFIT2:IFIT3 complex. This has enabled
us to examine the impact of hetero oligomerisation on IFIT
stability, RNA recognition and translation regulation and
to understand how this complex assembles.
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asymmetric unit are colored yellow and green with m7GpppAAAA bound in the cap-binding pocket highlighted in orange. The interface region between
the two IFIT1 molecules with Y460 and L464 side chains is enlarged (only labeled for the chain colored green). (B) Sequence alignment of the C-terminal
regions of IFIT1 and IFIT3 generated by Clustal Omega. The YxxxL motif is boxed. (C–F) UV280 absorbance traces of SEC analysis (SuperdexS200
Increase 10/300 column) of wild type (WT) and mutant IFIT1 alone or incubated with IFIT3. (D–F) Gel insets below each trace show SDS-PAGE
analysis of each run. Protein gel lanes and corresponding peaks are indicated by lower case letters. The position of IFIT1 and IFIT3 on the protein gels
is indicated. The Y460E/L464E+IFIT3 trace in F is adjusted by +10 milli absorbance units (mAU) for clarity. The elution profile of WT IFIT1+IFIT3 is
shown in grey shadow for reference. (G) Luciferase activity from RRL incubated with cap0--globin Fluc RNA andWT or mutant IFIT1 with or without
IFIT3 as indicated. Data are normalized to the luciferase activity in the absence of IFIT1 and shown as the mean ± the standard error of three separate
experiments. Statistical analysis was performed using an unpaired, two-tailed Students T-test. P values are indicated, and ∗ denotes statistical significance.
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Figure 6. IFIT3 stabilizes and promotes IFIT1 activity in cells. (A andB) HEK293T cells were transfected with the indicated amounts of plasmid encoding
FLAG-tagged versions of IFIT1, IFIT2 and IFIT3. After 24 hours cell lysates were harvested and analyzed by western blotting. (A) anti-FLAG and (B)
anti-IFIT1 blots are shown. Empty vector was used to normalize the amount of DNA used in each transfection. The blots shown are representative of three
separate experiments. (C) HEK293T cells were transfectedwith 1.5g of FLAG-taggedwild type (WT) ormutant IFIT1 and 1.5g of FLAG-tagged IFIT3
or empty vector as indicated. After 24 h cell lysates were analyzed as in A. The graph on right shows the quantification of the IFIT1 protein expression
relative to GAPDH probed as a loading control. Mean ± the standard deviation of three biological repeats. (D) Reporter luciferase was measured as
described in the Materials and Methods and expressed as the ratio of Fluc (cap0) over Nanoluc (cap1) signal, normalized to the empty vector control, and
shown as the mean ± the standard deviation of three biological repeats. Statistical analysis was performed using an unpaired, two-tailed Students t-test.
P-values are indicated, and * denotes statistical significance.
IFIT assembly
After initially confirming that IFIT1, IFIT2 and IFIT3 in-
teract in cell lysates in an RNA independent manner we
used SEC-MALS to examine IFIT heterocomplex assembly
pathways. Figure 7 shows schematic representations of each
of the IFIT complexes reconstituted in vitro in this study.
Comparison of the different complexes assembled in
vitro by differential scanning fluorimetry (Figure 2) re-
veals that although it is the least thermodynamically sta-
ble in isolation, the presence of IFIT3 enhances the stabil-
ity of both IFIT1 and IFIT2. However, our results demon-
strate that IFIT3 binds IFIT1 and IFIT2 in very different
ways. The IFIT1 and IFIT3 interaction is rapid and oc-
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Figure 7. Schematic representation of the IFIT complexes analyzed in this study. Cartoons depicting IFIT1 (yellow), IFIT2 (green) and IFIT3 (blue)
complexes reconstituted in vitro from individually purified proteins. Weak interactions are indicated by reversible arrows. IFIT1 and IFIT2 structures and
dimerization interactions have been characterized by X-ray crystallography (BioRxiv: https://doi.org/10.1101/152850 and (30)). No experimentally derived
structure for IFIT3 homo- or heterodimers are currently available. Therefore, IFIT3 and IFIT2:IFIT3 dimerisation, and IFIT1 heterooligomerization are
modeled on the IFIT1 dimer (PDB: 5W5H) and IFIT2 dimer (PDB: 4G1T) crystal structures and supported by experimental evidence as discussed in the
text. The association of IFIT1 and IFIT2 is less well defined as indicated by the question marks. A traffic light system is used to provide information on
the biological roles of the different complexes.
curs at low temperatures. We identified a critical YxxxL
motif present in both IFIT1 and IFIT3 that is essential
for interaction of the two proteins. This motif is also re-
sponsible for the concentration-dependent homodimeriza-
tion of IFIT1 previously reported (BioRxiv: https://doi.org/
10.1101/152850) and confirmed here. The dynamic nature
of the IFIT1:IFIT1 interaction likely accounts for the abil-
ity of IFIT3 to outcompete and form the thermodynami-
callymore stable IFIT1:IFIT3 complex. In contrast, the for-
mation of an IFIT2:IFIT3 complex from individually puri-
fied proteins is slow and requires energy, only being detected
when incubated at 37◦C. This is likely due to the domain
swap nature of the interaction between IFIT2 homodimers
that must be disrupted for IFIT3 to instead associate. Our
SEC-MALS analysis of IFIT2:IFIT3 heterodimer assembly
supports this model.
While the YxxxL motif is conserved in mouse Ifit1b1,
Ifit3 is truncated such that the YxxxL motif is absent
(Supplementary Figure S5). In mice and other rodents,
the Ifit1b1 gene has been duplicated (6) and it is possible
that these extra IFITs could compensate for the disrupted
murine Ifit1b1–Ifit3 interaction. This suggests species dif-
ferences in the role of this motif, and in IFIT oligomeri-
sation in general, that must be considered when examining
phenotypes of small animal models used to examine the im-
pact of IFIT depletion. Importantly, the crystal structure of
IFIT5 reveals that, although critical residues of the YxxxL
motif are conserved, they are buried in an interface with a
terminal helix not present in IFIT1 (8–10), explaining why
IFIT5 does not interact with IFIT3 ((12) and Figure 1).
Our IFIT2:IFIT3 interaction studies also have important
implications for our understanding of IFIT biology. IFIT2
dimerizes through a domain swap of three -helices that
Downloaded from https://academic.oup.com/nar/advance-article-abstract/doi/10.1093/nar/gky191/4937546
by University of Cambridge user
on 18 May 2018
Nucleic Acids Research, 2018 15
constitute one and a half TPRs of the N-terminal domain
(7) (Supplementary Figure S8A and shown schematically in
Figure 7). The ability of IFIT3 to sequester IFIT2 into a het-
erodimeric form demonstrates that IFIT3 can disrupt the
domain swapped architecture of IFIT2. It is therefore possi-
ble that IFIT3 could interact with IFIT2 in a similar domain
swapped manner (modeled schematically in Figure 7, top
right), consistent with TPRs 1–4 in the N terminus of IFIT2
being sufficient for the interaction (30). Overexpression of
IFIT2 induces apoptosis (30,43), while co-expression with
IFIT3 but not IFIT1 blocked this effect (30). Moreover, de-
pletion of IFIT3 induced cell death in the U549 human car-
cinoma cell line, an effect potentiated by co-infection with
dengue virus (44). Our data would suggest that the homod-
imeric form of IFIT2 may be responsible for this pheno-
type, and that co-expression of IFIT3 can mitigate this ef-
fect by disrupting IFIT2 dimerization. It is currently not
clear why the cell would evolve such a mechanism for in-
ducing programmed cell death. One potential hypothesis is
that dysregulation of ISG induction, perhaps due to infec-
tion, could perturb the balance of IFIT2 and IFIT3, pro-
moting cell death to restrict pathogen spread. Interestingly,
a poly(AU) RNA binding activity of IFIT2 was localized
to the dimer interface surfaces of the C-terminal domain
that form a large positively charged pocket (Supplementary
Figure S8B) (7). The electrostatic surface potential of an
IFIT3 molecular model, based on the IFIT2 crystal struc-
ture, is shown in Supplementary Figure S8C. The IFIT3
model lacks a positively-charged nucleic acid binding sur-
face like that of IFIT2. Together, our assembly analysis re-
veals novel details about IFIT interactions and indicates a
central role for IFIT3 in IFIT complex assembly.
Impact of oligomerization on IFIT1
In vitro reconstitution of the human IFIT heterocomplex
enabled us to examine the impact of oligomerization on the
cap0 mRNA binding and translation inhibition activity of
IFIT1. We opted to use an RRL based translation inhibi-
tion assay system as this was previously used to demon-
strate differential inhibitory effects of IFIT1 on mRNAs
from parainfluenza virus 5 (23). IFIT3 and to a lesser extent
the IFIT2:IFIT3 heterodimer enhanced the translation in-
hibition effect of IFIT1 on a ZV reportermRNA (Figure 3).
This effect was even more pronounced when a -globin re-
porter mRNA, predicted to have very little secondary struc-
ture, was analyzed consistent with an emerging consensus
that both the methylation state and structure at the 5′ end
of an mRNA can influence its susceptibility to IFIT1 inhi-
bition (9,23,24). IFIT2 alone did not enhance translation
inhibition by IFIT1 so it is likely that the effect observed
in the presence of the IFIT2:IFIT3 complex is a result of
IFIT1’s binding to IFIT3 in the complex. This can explain
why the effect of the IFIT1:IFIT2:IFIT3 complex in RRL
was weaker that the IFIT1:IFIT3 complex.
While multiple cellular factors such as competing cap-
binding proteins complicate analysis in lysates and cells, our
in vitro mRNA binding assays reveal that IFIT3 enhances
IFIT1 cap0 mRNA binding. When examined in our reverse
transcriptase inhibition assays, apparent IFIT1 binding was
much less efficient for the structured cap0-ZV reporter than
for the less structured -globin mRNA and in fact on the
ZV construct failed to reach saturation (Figure 4). This is
not due to incomplete capping of themRNAas saturation is
possible when IFIT3 is present. Instead, it is more likely that
the reverse transcriptase may remove a proportion of the
bound IFIT1 as it proceeds in a 5′ to 3′ direction resulting
in the production of a full-length signal even if IFIT1 was
initially bound. We conclude therefore that IFIT3 stabilizes
the interaction of IFIT1 with the cap0mRNA in such a way
that it is no longer removed by the reverse transcriptase con-
sistent with its role in enhancing translation inhibition by
IFIT1. Interestingly, there was no evidence of a shift in the
IFIT-dependent toeprint to indicate that the other IFITs in
the complex were interacting with the mRNA downstream
of the IFIT1 cap0 binding cleft. IFIT5 changes conforma-
tion when transitioning between the apo- and RNA-bound
state (8), positioning key residues for optimal RNA bind-
ing. The crystal structures of IFIT1 bound to different short
RNAs show the protein is in a similar closed conformation
as the RNA-bound structure of IFIT5 (9). It is therefore
likely that IFIT1 cycles through a similar open/closed con-
formation to interact withRNA.Binding of IFIT3may pro-
mote the closed conformation of IFIT1, stabilising its inter-
action with target RNAs.
Although the RRL system provides particular advan-
tages for analysis of translational control by IFIT com-
plexes it does not fully recapitulate the cellular environ-
ment that IFITs are exposed to. Using a cell-based system
we observed that IFIT3 markedly stabilizes the expression
of IFIT1 (Figure 6). This stabilization was dependent on
the integrity of the YxxxL IFIT1:IFIT3 interaction motif.
In contrast IFIT2 had a much smaller effect on IFIT1 ex-
pression in cells consistent with the stability of the differ-
ent complexes observed in the in vitro differential scanning
fluorimetry assays. Overexpression of wild type IFIT3, but
not an IFIT1-binding defective mutant, also enhanced the
translation inhibitory effect of IFIT1 on a model ZV re-
porter mRNA confirming that this interaction is function-
ally relevant. Therefore, through a single interaction surface
IFIT3 stabilizes the expression and enhances the non-self
mRNA binding activity of IFIT1.
IFIT1 puts pressure on viruses to maintain mechanisms
for generatingmRNAswith 5′ ends that it cannot bind. Fla-
viviruses for example, which have genomic RNAs ∼11000
bases in length, must dedicate a region of their limited
genome tomaintain a functional methyltransferase activity.
The genomic 5′ UTRs of alphaviruses, which lack a methyl-
transferase activity, also serve as replication promoters that
function more efficiently when unstructured. However, they
must forfeit optimal replication to maintain a stable stem
structure at the very end of their genomes to avoid IFIT1
restriction (26,27). Together, our results provide novel de-
tails about IFIT interactions and how oligomerisation af-
fects IFIT1 stability, non-self RNA binding and transla-
tion inhibition. Our reconstituted complexes provide a solid
foundation for future molecular analysis of IFIT assembly
and function.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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